Reflections on 2014 – Enthusiasm for 2015

Al B. Benson III, MD, FACP, FASCO

Letter to Our Readers

Dear Colleague,

What an incredible year for the oncology community. We have witnessed great strides in our ability to fight cancer, most notably with immunotherapeutics. As a result, we have glimpsed a possible future of cancer care that will cater to the individual patient, making personalized medicine a reality, and ultimately improve the lives of our patients. In addition to the advances in immunotherapy, we have presented important, timely information on targeted therapies, diagnostics, and biomarker identification. What is the most effective way to present this information? That depends on the reader. To better meet the individual needs of our readership, Personalized Medicine in Oncology (PMO) extends its reach beyond the print journal alone. We are pleased to offer additional resources to disseminate information to our valued readership, including:

• Immunotherapy in Oncology
  The publishers of PMO proudly present this timely journal focusing on the significant role of
  immunotherapies in the treatment of many cancers.
  
• World Cutaneous Malignancies Congress (WCMC)
  As one of the official meetings of PMO, this dynamic congress offers an expert international
  faculty and is dedicated to fostering the exchange of clinically relevant information in the field of cutaneous malignancies.
  
• PMO Live: A Global Biomarkers Consortium Initiative
  The only global meeting dedicated to advancing the understanding of the value and clinical impact of biomarker research in oncology. Guided by the expertise of leaders in this field, participants will achieve a thorough understanding of the relevance of biomarkers in effectively personalizing cancer care in the clinical setting.
  
• Continuing Medical Education (CME)
  To meet the continuing educational needs of our reading community, you’ll find CME opportunities in many of our issues and on our website.
  
• PersonalizedMedOnc.com
  We designed our website to be a valuable resource complete with information from all our offerings.

Thank you for your loyal readership throughout 2014. We look forward to serving you in the coming year by bringing you the latest advances in personalized care in the hope of enhancing your ability to care for patients. Any suggestions as to how we can better serve you are welcome and should be addressed to our editorial director at ksiyahian@the-lynx-group.com. Our very best to you this holiday season and in the new year.

Sincerely,

Sanjiv S. Agarwala, MD
Coeditor in Chief
Personalized Medicine in Oncology

Al B. Benson III, MD, FACP, FASCO
Coeditor in Chief
Personalized Medicine in Oncology

Related Articles